Omri Amirav-Drory

Omri Amirav-Drory is a board member at Pangea Biomed. Omri has also worked at resistanceBio, Talus Bio, La Jolla Labs, Mana.bio, PANGEA Therapeutics, Pepper Bio, Nanocarry Therapeutics, Gilboa Therapeutics and NFX.

Omri Amirav-Drory completed a Bachelor of Science at Tel Aviv University in Biochemistry and Molecular Biology. Omri then went on to complete a Doctor of Philosophy (Ph.D.) at Tel Aviv University in Biochemistry. After that, they did a postdoctoral program in Biochemistry and Molecular Biology at Stanford University.